Buscar | Knowlexaconnect

agregó una foto Health

2026-01-30 09:21:22 -

Targeting the Cell Cycle to Safeguard Hope: The Clinical Value and Development of CDK4/6 Inhibitors

Written by DengyuePharma As cancer treatment enters the era of precision medicine, the emergence of each novel targeted therapy has brought renewed hope to countless patients. CDK4/6 inhibitors, a class of targeted agents focusing on cell cycle regulation, have established a central role in the treatment of hormone receptor–positive (HR+), human epidermal growth factor receptor...

0 Commentarios 0 Acciones 79 Views 0 Vista previa